MEDP
Medpace Holdings, Inc.
Diagnostics & Research · Healthcare · United States
581.95
close · 2026-08-13
value
22
cheaper than peers22
quality
95
stronger fundamentals95
ranked against
Diagnostics & Research
value
quality
28 peers
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 26.13× | 44 |
| forward P/E | 30.14× | 39 |
| price to sales | 5.80× | 39 |
| price to book | 37.44× | 2 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 162.2% | 98 |
| operating margin | 20.8% | 83 |
| debt to equity | 33.2% | 67 |
| revenue growth | 17.2% | 63 |
4 of 4 measures available
Facts
| market cap | $16B |
| free cash flow | $510.4M |
| employees | 6,500 |
| first trade | 2016-08-11 |
| next earnings | 2026-07-22 |
| fundamentals updated | 2026-07-30 |